Dawn of precision medicine on gastric cancer

Takahiro Ishii1, Akihito Kawazoe1, Kohei Shitara2

  • 1Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Abstract

Insights

Advances in understanding gastric cancer biology are guiding targeted therapies and immune checkpoint inhibitors. Further research aims to improve treatment selection for precision medicine in gastric cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Recent progress has improved understanding of gastric cancer biology and molecular features.
  • This knowledge aids in patient stratification and the development of targeted therapies.
  • The effectiveness of PD-1 blockade is currently limited to a subset of advanced gastric cancer patients.

Purpose of the Study:

  • To review preclinical and clinical studies on molecular features, treatment targets, and immune checkpoint inhibitors in gastric cancer.
  • To explore the potential for novel therapeutic strategies and biomarkers in gastric cancer.

Main Methods:

  • Literature review of studies indexed in PubMed.
  • Analysis of congress webpages from the American Society of Clinical Oncology and European Society of Medical Oncology.
  • Focus on molecular features, targeted therapies, and immune checkpoint inhibitors in gastric cancer.

Main Results:

  • Next-generation sequencing has elucidated the genomic landscape of gastric cancer, leading to proposed molecular classifications and identified subtypes.
  • Clinical trials are underway for novel agents including receptor tyrosine kinase inhibitors, antibody-drug conjugates, and IMAB362 (anti-Claudin 18.2).
  • Biomarkers for predicting response to immune checkpoint inhibitors and combination therapies are under active investigation.

Conclusions:

  • Advances in understanding molecular profiles facilitate the development of novel gastric cancer agents.
  • Improved treatment selection for immune checkpoint inhibitors and combination therapies is crucial.
  • These developments pave the way for precision medicine in gastric cancer.

Related Concept Videos

Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.0K
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.5K
Gastric Phase of Digestion01:26

Gastric Phase of Digestion

The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
3.2K
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
100.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.0K
Accuracy and Precision01:52

Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value.  Highly accurate...
14.9K